SCHEMBL12424181

SCHEMBL12424181

Cc1cc(F)cc(-c2onc(-c3ccccc3F)c2C(O)c2cccnc2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.39
BRD4 O60885 1/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
LMNA P02545 1/20 0.36
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
KCNA5 P22460 3/20 0.33
PIM1 P11309 1/20 0.33
CYP17A1 P05093 1/20 0.33
CTSA P10619 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2198367 0.93 SMN1; SMN2 (0.40) ATMBRD4KMT2AGAASMN1; SMN2
SCHEMBL2198584 0.82 ATM (0.40) ATMBRD4KMT2AGAASMN1; SMN2
SCHEMBL12424176 0.81 BRD4 (0.43) ATMBRD4KMT2AGAASMN1; SMN2
SCHEMBL2196223 0.80 SMN1; SMN2 (0.38) ATMBRD4KMT2AGAASMN1; SMN2
SCHEMBL2197749 0.79 ATM (0.38) ATMBRD4KMT2ASMN1; SMN2L3MBTL1
SCHEMBL3124272 0.78 ATM (0.39) ATMGAASMN1; SMN2L3MBTL1LMNA
SCHEMBL2198078 0.77 TSHR (0.44) ATMBRD4KMT2AGAASMN1; SMN2
SCHEMBL2197672 0.77 KCNA5 (0.39) ATMBRD4KMT2AGAASMN1; SMN2
SCHEMBL2259888 0.77 SMN1; SMN2 (0.38) ATMBRD4KMT2AGAASMN1; SMN2
SCHEMBL2197807 0.77 CYP2A6 (0.39) ATMBRD4GAASMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977341-B2 For crops; 3-(2,6-Dichlorophenyl)-4-[(3-pyridyl)hydroxymethyl]-5-trimethylsilylisoxazole for example SYNGENTA LIMITED (GB) 2011-07-12 US disclosed
US-7977341-B2 For crops; 3-(2,6-Dichlorophenyl)-4-[(3-pyridyl)hydroxymethyl]-5-trimethylsilylisoxazole for example SYNGENTA LIMITED (GB) 2011-07-12 US disclosed
US-20080096843-A1 Substituted Isoxazoles as Fungicides SYNGENTA LIMITED (GB) 2008-04-24 US disclosed
US-20080096843-A1 Substituted Isoxazoles as Fungicides SYNGENTA LIMITED (GB) 2008-04-24 US disclosed
US-7338967-B2 Substituted isoxazoles as fungicides SYNGENTA LIMITED (GB) 2008-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096843-A1 Substituted Isoxazoles as Fungicides CYP4X1, CYP51A1, CYP3A7 ATM 3589/4885BRD4 3717/4885KMT2A 1843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.